Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹151Cr
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

GAYATRIBI
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | -100.0 | | | | | | | |
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit Operating ProfitCr |
| -38.3 | | | | | | | | | | | |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -378.6 | -25.0 | 75.6 | -16.7 | 65.7 | -5.0 | -63.6 | -14.3 | 26.1 | -23.8 | -16.7 | -37.5 |
| -40.1 | | | | | | | | | | | |
| -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 19.5 | -46.1 | -42.3 | 117.6 | -10.3 | -100.0 | | | | -100.0 | | |
| 241 | 163 | 129 | 197 | 159 | 1 | 1 | 1 | 2 | 1 | 0 | 1 |
Operating Profit Operating ProfitCr |
| 6.0 | -18.0 | -61.8 | -13.8 | -2.3 | | | | -46.1 | | | |
Other Income Other IncomeCr | 1 | 1 | -17 | 12 | 2 | 85 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 9 | 13 | 12 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 2 | 2 | 5 | 7 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | -39 | -83 | -19 | -16 | 84 | -1 | -1 | -1 | -1 | -1 | -1 |
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 190.5 | -1,084.9 | -113.4 | 76.8 | 19.0 | 644.7 | -100.6 | 0.3 | -103.7 | 32.6 | -6.7 | -18.4 |
| 1.5 | -28.0 | -103.7 | -11.0 | -10.0 | | | | -60.6 | | | |
| 0.3 | -6.3 | -10.6 | -2.7 | -1.9 | 10.7 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 51 | 62 | 79 | 79 | 79 | 79 | 79 | 79 | 79 | 79 | 79 | 79 |
| -41 | -80 | -160 | -181 | -196 | -111 | -112 | -112 | -113 | -114 | -115 | -115 |
Current Liabilities Current LiabilitiesCr | 82 | 124 | 184 | 246 | 260 | 34 | 34 | 34 | 34 | 34 | 34 | 34 |
Non Current Liabilities Non Current LiabilitiesCr | 19 | 15 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 88 | 88 | 105 | 145 | 145 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
Non Current Assets Non Current AssetsCr | 55 | 54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | -26 | -14 | -3 | -1 | 85 | -1 | 0 | -1 | -1 | -1 |
Investing Cash Flow Investing Cash FlowCr | -7 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 4 | 28 | 16 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
|
Free Cash Flow Free Cash FlowCr | 1 | -27 | -16 | -3 | -1 | 85 | -1 | 0 | -1 | -1 | -1 |
| 27.3 | 68.4 | 16.6 | 13.7 | 3.8 | 100.1 | 104.0 | 81.5 | 55.8 | 101.9 | 75.8 |
CFO To EBITDA CFO To EBITDA% | 7.0 | 106.7 | 27.9 | 11.0 | 16.3 | -13,885.1 | 104.2 | 81.6 | 73.4 | 130.5 | 122.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 44 | 57 | 130 | 52 | 17 | 10 | 51 | 148 | 56 | 39 | 54 |
Price To Earnings Price To Earnings | 11.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.2 | 0.4 | 1.6 | 0.3 | 0.1 | | | | 33.8 | | |
Price To Book Price To Book | 4.4 | -3.2 | -1.6 | -0.5 | -0.1 | -0.3 | -1.5 | -4.4 | -1.6 | -1.1 | -1.5 |
| 6.0 | -5.6 | -3.4 | -3.7 | -14.2 | -73.3 | -172.1 | -368.7 | -119.9 | -142.5 | -201.5 |
Profitability Ratios Profitability Ratios |
| 18.5 | 1.4 | 45.3 | 18.4 | 28.6 | | | | 4.8 | | |
| 6.0 | -18.0 | -61.8 | -13.8 | -2.3 | | | | -46.1 | | |
| 1.5 | -28.0 | -103.7 | -11.0 | -10.0 | | | | -60.6 | | |
| 23.7 | -38.5 | 154.4 | 28.2 | 13.2 | 3,219.7 | -23.4 | -30.4 | -65.3 | -44.5 | -44.6 |
| 39.1 | 217.5 | 101.9 | 18.7 | 13.3 | -260.1 | 1.5 | 1.5 | 2.9 | 1.9 | 2.0 |
| 2.8 | -27.3 | -78.9 | -13.2 | -10.7 | 2,730.4 | -19.2 | -22.2 | -62.5 | -43.2 | -43.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Gayatri BioOrganics Limited is an Indian industrial manufacturer specializing in the production of **Starch**, its **derivatives**, and related **by-products**. The company focuses on the development of **customized applications** for value-added starch derivatives to serve diverse industrial requirements. Listed on the **BSE Limited (ISIN: INE052E01015)**, the company is currently navigating a strategic transition phase characterized by promoter consolidation and a restructuring of its manufacturing operations.
---
### **Core Operations and Industrial Infrastructure**
The company maintains a manufacturing presence across two primary locations in Southern India, focusing on a **single reportable segment** of starch and related products.
* **Manufacturing Footprint:** Production facilities are located in the states of **Telangana** and **Karnataka**.
* **Corporate Hub:** The registered office is situated in **Hyderabad, Telangana**.
* **Product Portfolio:**
* **Maize Starch:** Primary industrial starch products.
* **Starch Derivatives:** Modified starches for specialized industrial use.
* **Value-Added Applications:** Customized starch solutions tailored to specific client requirements.
* **By-products:** Related outputs from the starch manufacturing process.
---
### **Strategic Promoter Consolidation and Ownership Structure**
As of **July 2024**, Gayatri BioOrganics is undergoing a significant consolidation of its leadership and ownership structure. This **inter-se transfer** of equity among the promoter group is designed to streamline shareholding under primary leadership, potentially simplifying future corporate actions and decision-making.
The restructuring is conducted under **Regulation 29 (1) & (2)** and **Regulation 10** of the **SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011**.
**Key Acquisition Details (July 2024):**
The lead promoter, **T V Sandeep Kumar Reddy**, initiated the acquisition of **1,26,48,171** fully paid-up equity shares through off-market transactions (gifts and purchases).
| Transferor / Donor Entity | Shares Transferred | % of Holding |
| :--- | :--- | :--- |
| **Tikkavarapu Sarita Reddy** | **48,80,279** | **6.19%** |
| **TSR Holdings Private Limited** | **20,26,000** | **2.57%** |
| **Subbarami Reddy Tikkavarapu** | **16,25,000** | **2.06%** |
| **Gayatri Fin Holdings Private Limited** | **15,70,950** | **1.99%** |
| **Indira Subbaramireddy Tikkavarapu** | **45,602** | **0.06%** |
| **Total Acquisition Volume** | **1,26,48,171** | **-** |
---
### **Financial Profile and Capital Structure**
The company’s financial position is defined by a transition following a **Business Transfer Agreement (BTA)** in **November 2016**, which involved the transfer of manufacturing units. While the company has seen a modest resumption of revenue, it continues to manage a significant debt burden and negative net worth.
**Comparative Financial Performance:**
| Metric | FY 2022-23 | FY 2021-22 |
| :--- | :--- | :--- |
| **Total Revenue** | **₹ 166.74 Lakhs** | **Nil** |
| **Net Loss** | **₹ 1.01 Crore** | **₹ 49.61 Lakhs** |
| **Reserves & Retained Earnings** | **₹ (11,327.36) Lakhs** | **-** |
| **Dividend Recommended** | **Nil** | **Nil** |
**Capital and Debt Composition:**
* **Authorized Share Capital:** **₹ 90 Crore** (9,00,00,000 equity shares of **₹ 10** each).
* **Paid-up Share Capital:** **₹ 78.79 Crore** (7,87,88,142 equity shares of **₹ 10** each).
* **Unsecured Term Loans (Non-Current):** Totaling **₹ 295.73 Crore** (increased from **₹ 225.73 Crore**).
* **Promoter Debt:** **₹ 182.79 Crore** provided by **Mr. T Sandeep Reddy**. Following the 2016 BTA, interest on this loan was waived (previously **15% p.a.**). It currently has **no fixed repayment term** and is repayable only upon achieving **adequate cash profits**.
* **Inter-Corporate Deposits (ICD):** **₹ 112.94 Crore**, carrying an interest rate of **18% p.a.** (Standard inter-corporate loans are generally carried at **15% p.a.**).
---
### **Operational Stability and "Going Concern" Status**
Despite a negative net worth of **₹ (113.27) Crore**, the company continues to operate on a **"going concern"** basis. This status is underpinned by:
* **Promoter Support:** A **Comfort Letter** provided by the promoters ensures ongoing financial backing.
* **Debt Management:** The company has **not** been declared a **Wilful Defaulter** by any bank or financial institution.
* **Compliance:** There are no **unpaid or unclaimed dividends**, and no material changes have occurred in the **nature of business** or financial position since the last reporting date.
---
### **Enterprise Risk Management (ERM) Framework**
The company employs a structured ERM framework overseen by a **Risk Management Committee**. Risks are prioritized based on **severity**, **likelihood**, and **detection effectiveness**, with **quarterly reviews** by senior management.
#### **Financial & Liquidity Risks**
* **Credit Risk:** Primarily concentrated in **Trade Receivables** and **Cash and Bank Balances**. The company monitors counterparty obligations closely to prevent financial loss.
* **Liquidity Risk:** Managed by investing surplus funds in **marketable securities** and other financial instruments to support **short-term operational needs** and **long-term growth projects**.
#### **Legal and Regulatory Exposures**
* **Litigation:** The company is involved in ordinary-course legal proceedings and claims.
* **Taxation:** Management is currently contesting specific **tax demands**. While the timing of cash outflows is subject to pending judgments, the company maintains that these will not have a **material adverse effect** on its financial position.
#### **Strategic and Operational Oversight**
The ERM framework actively monitors a broad spectrum of threats, including:
* **Market and Strategic Risk**
* **Security and IT Risk**
* **Property and Reputational Risk**
* **Regulatory and Compliance Risk**
| Risk Category | Primary Focus Areas | Mitigation Strategy |
| :--- | :--- | :--- |
| **Credit** | Trade Receivables, Counterparty obligations | Monitoring concentration of credit and bank balances. |
| **Liquidity** | Short-term operations, Long-term growth | Investment in **marketable securities**; maintaining surplus liquidity. |
| **Legal** | Tax demands, Ordinary course litigation | Appellate process engagement; professional tax advisory. |
| **Governance** | Enterprise-wide framework | **Quarterly reviews** by Senior Management and Board oversight. |